Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0037278
Disease: Skin Diseases, Infectious
Skin Diseases, Infectious
0.100 Biomarker group BEFREE Coupled to a low cytotoxic activity, we believe our lead compound can be developed into a topical antibacterial agent to replace mupirocin as the first-line drug for treating MRSA skin infections. 30103288 2019
CUI: C0037278
Disease: Skin Diseases, Infectious
Skin Diseases, Infectious
0.100 Biomarker group BEFREE Our findings revealed that pvl-positive MRSA associated with deep-seated skin infections are spreading in Japanese communities, particularly in Ishigaki, Okinawa. 28552322 2017
CUI: C0037278
Disease: Skin Diseases, Infectious
Skin Diseases, Infectious
0.100 Biomarker group BEFREE An in vivo BALB/c mice, skin infection models revealed that treatment with VM-loaded polymersomes significantly reduced the MRSA burden compared with plain VM and blank polymersomes. 27890573 2017
CUI: C0037278
Disease: Skin Diseases, Infectious
Skin Diseases, Infectious
0.100 Biomarker group BEFREE Moreover, PLNA34 showed high levels of protection in the CA-MRSA mouse skin infection model. 27718524 2017
CUI: C0037278
Disease: Skin Diseases, Infectious
Skin Diseases, Infectious
0.100 GeneticVariation group BEFREE Eradication treatment of MRSA spa types causing more skin infections may be warranted. 23922169 2014
CUI: C0037278
Disease: Skin Diseases, Infectious
Skin Diseases, Infectious
0.100 Biomarker group BEFREE Our results showed that PVL was strongly associated with pyomyositis and osteomyelitis, and that there is a high prevalence of PVL-MRSA skin infections in Benin. 23924370 2013
CUI: C0037278
Disease: Skin Diseases, Infectious
Skin Diseases, Infectious
0.100 Biomarker group BEFREE Pulsed-field type USA300 were MRSA, PVL-positive, unencapsulated strains that were associated with deep skin infections and recurrent disease. 21631600 2011
CUI: C0037278
Disease: Skin Diseases, Infectious
Skin Diseases, Infectious
0.100 Biomarker group BEFREE In an area where PVL-containing MRSA is prevalent, skin infection risk was increased among MRSA nasal carriers compared with methicillin-susceptible S. aureus carriers and noncarriers, but risk differential diminished over time. 20409369 2010
CUI: C0037278
Disease: Skin Diseases, Infectious
Skin Diseases, Infectious
0.100 Biomarker group BEFREE Community-based intervention to manage an outbreak of MRSA skin infections in a county jail. 20466702 2010
CUI: C0037278
Disease: Skin Diseases, Infectious
Skin Diseases, Infectious
0.100 Biomarker group BEFREE CA-MRSA strains most commonly cause skin infections, but may lead to more severe diseases, and consequently the patient's death. 20544179 2010
CUI: C0037278
Disease: Skin Diseases, Infectious
Skin Diseases, Infectious
0.100 Biomarker group BEFREE We report the first complete genome sequence of an ST93-MRSA-IV clinical isolate that caused severe invasive infection and a familial outbreak of skin infection. 20729356 2010
CUI: C0037278
Disease: Skin Diseases, Infectious
Skin Diseases, Infectious
0.100 Biomarker group BEFREE Topical retapamulin (Altabax, Altargo) is the first pleuromutilin antibacterial approved for the treatment of uncomplicated superficial skin infections caused by Staphylococcus aureus (excluding methicillin-resistant S. aureus [MRSA]) and Streptococcus pyogenes in patients aged > or = 9 months. 18973410 2008
CUI: C0037278
Disease: Skin Diseases, Infectious
Skin Diseases, Infectious
0.100 Biomarker group BEFREE Identifying CA-MRSA virulence determinants and the concerted regulation of these factors will foster development of vaccines and therapeutics designed to control CA-MRSA skin infections. 18317037 2008
CUI: C0037278
Disease: Skin Diseases, Infectious
Skin Diseases, Infectious
0.100 Biomarker group BEFREE We conducted S. aureus surveillance in the outbreak region and a case-control study in 1 community, comparing 34 case patients with MRSA skin infection with 94 control subjects. 15116291 2004